The UK’s drugs regulator—the MHRA—has approved the Alzheimer’s drug donanemab, but it won’t be available on the NHS.
This article was originally published on MedicalXpress.com
Alzheimer’s drug approved in the UK, but it won’t be available on the NHS—here’s why
You may also be interested in:
The Latest
Exploring Attachment Styles and How They Affect Adult Relationships
Do you want to know more about attachment types and adult relationships? If so, you’ve come to the right place! In this blog, we’ll examine how different attachment styles impact our relationships and how understanding […]
The Latest
Will a nutritional supplement help you run better?
Whether you jog to keep fit or compete in marathons, the physically demanding sport of running can deplete the body of essential nutrients. During a race like a half-marathon, a runner’s metabolism — or ability […]
The Latest
Why stress-related illness is so hard to diagnose, and how a patient-centred playful approach can help
For at least three decades, researchers have gathered evidence that chronic stress puts pressure on the body to constantly adjust itself to restore physiological stability. This process is known as allostatic load and it creates a cascade […]
Read More:
-
A new paper in the journal Child Development shows how some aspects of family interaction among Indigenous people in Guatemala have fundamentally shifted with rapid [...]
-
As teens continue to spend more time on screens and social media, a new study finds that among 11-12-year-olds, excessive time online is associated with [...]
-
Can artificial intelligence-powered tools help enrich child development and learning?This article was originally published on MedicalXpress.com
